Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Anika Therapeutics Inc. (NASDAQ: ANIK).

Full DD Report for ANIK

You must become a subscriber to view this report.


Recent News from (NASDAQ: ANIK)

New Research: Key Drivers of Growth for Edison International, NuVasive, LogMein, Anika Therapeutics, First Industrial Realty Trust, and ON Semiconductor - Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Nov. 02, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Edison International (NYSE:EIX), NuVasive, Inc. (NASDAQ:NUVA), LogMein...
Source: GlobeNewswire
Date: November, 02 2018 08:55
Anika Therapeutics Inc. 2018 Q3 - Results - Earnings Call Slides
The following slide deck was published by Anika Therapeutics Inc. in conjunction with their 2018 Q3 earnings Read more ...
Source: SeekingAlpha
Date: October, 25 2018 13:36
Anika to Participate in the 2018 Morgan Stanley Global Healthcare Conference on September 12, 2018
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , today announced that its President and Chief Executive Officer, Joseph Darling, and Chief F...
Source: Business Wire
Date: September, 05 2018 16:05
Anika Appoints Dr. Cheryl Blanchard to Its Board of Directors
Anika Therapeutics, Inc. (NASDAQ: ANIK) (“Anika” or the “Company”), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology , today announced that Che...
Source: Business Wire
Date: September, 05 2018 16:05
Singular Research EPS Surprises For Q2 2018
Earnings Surprises and Disappointments for Q2 2018 Top Surprises JMP Group LLC ( JMP ) +256% JMP data by YCharts Had record investment banking revenues Increased accumulation of loans leading up to the CLO V pricing Had a favorable exit from a principal investment Inves...
Source: SeekingAlpha
Date: September, 04 2018 13:17
Analysis: Positioning to Benefit within Anika Therapeutics, Ameris, Century Communities, Energous, Consolidated Communications, and Globalstar - Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Anika Therapeutics Inc. (NASDAQ:ANIK), Ameris Bancorp (NASDAQ:ABCB), Cent...
Source: GlobeNewswire
Date: August, 07 2018 07:50
Anika Therapeutics: Strong Earnings Coupled With Improving Prospects
If we become increasingly humble about how little we know, we may be more eager to search. - Sir John Templeton Anika Therapeutics (NASDAQ: ANIK ) is a highly interesting company, and one of our core holdings in the long-term (CP-Alpha) portfolio of Integrated BioSci Investing. Despite t...
Source: SeekingAlpha
Date: August, 02 2018 05:25
Blog Exposure - CHMP Adopts Positive Opinion for Alnylam's Patisiran for HATTR Amyloidosis Treatment
Stock Monitor: Anika Therapeutics Post Earnings Reporting LONDON, UK / ACCESSWIRE / July 31, 2018 / If you want access to our free research report on Alnylam Pharma, Inc. (NASDAQ: ALNY ), all you need to do is sign up now by clicking the following link www.active-investors.com/registr...
Source: ACCESSWIRE IA
Date: July, 31 2018 07:15
Anika Therapeutics Inc. (ANIK) CEO Joseph Darling on Q2 2018 Results - Earnings Call Transcript
Anika Therapeutics Inc. (ANIK) Q2 2018 Earnings Conference Call July 26, 2018 09:00 AM ET Executives Sylvia Cheung - Chief Financial Officer Joseph Darling - President and Chief Executive Officer Analysts Joe Munda - First Analysis Lisa Springer - Singular Research Jim Si...
Source: SeekingAlpha
Date: July, 26 2018 14:59
Anika up 18% after Q2 beat
Thinly traded Anika Therapeutics ( ANIK +17.6% ) is up on almost 75% higher volume, albeit on turnover of only 480K shares, on the heels of its Q2 results released yesterday after the close. More news on: Anika Therapeutics Inc., Healthcare stocks news, Stocks on the move, Read mor...
Source: SeekingAlpha
Date: July, 26 2018 13:26

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0841.7541.5342.127641.2553,860
2018-05-1739.6339.0340.6238.94162,530
2017-06-2047.2947.3347.7344.01119,213
2017-06-1945.4847.3147.6245.35248,973
2017-06-1645.4445.3246.1644.95153,693

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1427,45851,78453.0241Short
2018-12-138,73330,93328.2320Cover
2018-12-124,51122,01120.4943Cover
2018-12-1136,58168,29253.5656Short
2018-12-1019,46843,79644.4515Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ANIK.


About Anika Therapeutics Inc. (NASDAQ: ANIK)

Logo for Anika Therapeutics Inc. (NASDAQ: ANIK)

Not available

 

Contact Information

 

 

Current Management

  • Douglas R. Potter / CEO, CFO

Current Share Structure

  • Market Cap: $558,075,385 - 05/14/2018
  • Issue and Outstanding: 14,693,928 - 02/09/2018

 


Recent Filings from (NASDAQ: ANIK)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 17 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 17 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: April, 06 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: March, 22 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 08 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 21 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 13 2018

 

 


Daily Technical Chart for (NASDAQ: ANIK)

Daily Technical Chart for (NASDAQ: ANIK)


Stay tuned for daily updates and more on (NASDAQ: ANIK)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ANIK)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ANIK is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ANIK and does not buy, sell, or trade any shares of ANIK. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/